Fundraising Fox

Windgap Medical

Watertown, US · Founded 2011 · Delaware corporation · 4 known investors

Windgap Medical designs autoinjector devices for delivering complex drugs and combination products, including systems for reconstituting lyophilized or powdered compounds, sequential delivery of two liquid therapies, high-viscosity medications, and large-volume injections. It serves biopharmaceutical companies developing drug-device combination products.

BiotechHardwareMedical Devices

Founders & leadership

Windgap Medical was founded in 2011 by Brent Buchine.

BBBrent Buchine
Brent BuchineinCo-Founder and Chief Business Officer (CBO)
MMMax Meehan
Max MeehanExecutive
AMAaron Mann
Aaron MannExecutive
JDJason Durkin
Jason DurkinExecutive
JC
John CadiganExecutive
AWAnthony Watson
Anthony WatsonExecutive
CS
Christopher StepanianNamed on SEC filing

Board

RR
Richard RussellBoard director
TK
Timothy KrochukBoard director
JR
John Reading WilsonBoard director
TK
Tim KrochukBoard director
JCJohn Conley
John ConleyinBoard directorBoard Member at Launchpad Venture Group

Investors · 4

Bantam GroupWestwood
Boston Harbor AngelsBoston · $250K – $1.5M
Colle Capital PartnersNew York · $500K – $2M
Launchpad Venture GroupBoston · $8M – $10M

Reported raises · per SEC filings

Form D private placements

$77M disclosed across 9 rounds · 2014–2023

▶$12.7MraisedJan 2026 · 13 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Max MeehanExecutive Officer
  • Richard RussellDirector
  • Brent BuchineDirector
  • Timothy KrochukDirector
  • Aaron MannExecutive Officer, Director
  • Jason DurkinExecutive Officer
  • John CadiganExecutive Officer
  • Anthony WatsonExecutive Officer
  • John Reading WilsonDirector
Offering amount
$17.3M
Amount sold
$12.7M
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$39.2MraisedJan 2022 · 46 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael HuangDirector
  • Richard RussellDirector
  • John Reading WilsonDirector
  • Christopher StepanianExecutive Officer, Director
  • Brent BuchineExecutive Officer, Director
  • John ConleyDirector
Offering amount
$42.2M
Amount sold
$39.2M
First sale
Aug 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$360.5KraisedMar 2020 · 20 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Brent BuchineExecutive Officer, Director
  • Christopher StepanianExecutive Officer, Director
  • J. Melville EngleDirector
  • John ConleyDirector
  • Tim KrochukDirector
  • John Reading WilsonDirector
  • Richard GabrielDirector
Offering amount
$2M
Amount sold
$360.5K
First sale
Feb 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.2MraisedJan 2019 · 106 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John Reading WilsonDirector
  • Richard GabrielDirector
  • John ConleyDirector
  • J. Melville EngleDirector
  • Tim KrochukDirector
  • Brent BuchineExecutive Officer, Director
  • Christopher StepanianExecutive Officer, Director
Offering amount
$39M
Amount sold
$12.2M
First sale
Jan 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.8MraisedJul 2018 · 75 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard GabrielDirector
  • J. Melville EngleDirector
  • Tim KrochukDirector
  • Christopher StepanianExecutive Officer, Director
  • Brent BuchineExecutive Officer, Director
  • John ConleyDirector
Offering amount
$4M
Amount sold
$3.8M
First sale
May 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.9MraisedApr 2016 · 46 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher StepanianExecutive Officer, Director
  • Richard GabrielDirector
  • Tim KrochukDirector
  • J. Melville EngleDirector
  • John ConleyDirector
  • Brent BuchineExecutive Officer, Director
Offering amount
$4M
Amount sold
$2.9M
First sale
Mar 2016
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.2MraisedAug 2015 · 92 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John ConleyDirector
  • Richard GabrielDirector
  • Brent BuchineExecutive Officer, Director
  • Christopher StepanianExecutive Officer, Director
  • Tim KrochukExecutive Officer
  • J. Melville EngleDirector
Offering amount
$4.5M
Amount sold
$4.2M
Minimum investment
$4.2K
Proceeds to insiders
$465K
First sale
May 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$250KraisedMay 2015 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • J. Melville EngleDirector
  • Tim KrochukDirector
  • John ConleyDirector
  • Richard GabrielDirector
  • Brent BuchineExecutive Officer, Director
  • Christopher StepanianExecutive Officer, Director
Offering amount
$250K
Amount sold
$250K
Minimum investment
$250K
First sale
May 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Cqmedical5 shared keywordsCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.

Companies competing with Windgap Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

EpiPen rival raises $39M to fund smaller, longer-lasting product | Fierce Pharmafiercepharma.com · Jan 2022Windgap Medical Closes Over $39M Series B-1 Fundingfinsmes.com · Jan 2022Windgap Medical, Inc. Closes Over $39 Million of Series B-1 Investment, More Than Twenty Percent Over Its Initial Goal — Windgap Medicalwindgapmedical.com · Jan 2022Drug Delivery Startup Windgap Medical Raises $17 mln In Series B Funding - Grit Daily Newsgritdaily.com · Sep 2021Windgap Medical Announces Strategic Investment from Molex Ventures — Windgap Medicalwindgapmedical.com · Jan 2019Windgap Medical raises $3m for epinephrine auto-injector - MassDevicemassdevice.com · Apr 2016

Frequently asked questions

What does Windgap Medical do?
Windgap Medical designs autoinjector devices for delivering complex drugs and combination products, including systems for reconstituting lyophilized or powdered compounds, sequential delivery of two liquid therapies, high-viscosity medications, and large-volume injections. It serves biopharmaceutical companies developing drug-device combination products.
Who founded Windgap Medical?
Windgap Medical was founded by Brent Buchine in 2011.
Who are Windgap Medical's investors?
Windgap Medical's investors include Bantam Group, Boston Harbor Angels, Colle Capital Partners, Launchpad Venture Group.
How much funding has Windgap Medical raised?
Windgap Medical has disclosed $77M raised across 9 rounds.
Where is Windgap Medical headquartered?
Windgap Medical is headquartered in Watertown, US.